MedTrace Logo

Local Proof of Concept of Evira in Abu Dhabi Study

NCT06665893 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2024-10-30

No results posted yet for this study

Summary

Evira is a digital treatment tool developed for treatment of childhood obesity. Through daily weighings at home using a special scale together with a message function in the Evira application, parents and the clinicians can easily follow the child's weight development. The primary aim of this study is to evaluate its efficacy for childhood obesity treatment in Abu Dhabi, with a secondary objective to establish non-inferiority compared to outcomes in a cohort in Stockholm, Sweden.

Conditions

  • Childhood Obesity
  • Adolescent Obesity
  • Treatment Adherence

Interventions

DEVICE

Digi-physical treatment tool

A support tool named Evira will be used to provide behavioral treatment. Through daily weightings at home using a special designed scale, which sends data directly to an application on the parents phone and to a clinic homepage, the child's weight development can be easily monitored.

Sponsors & Collaborators

  • Karolinska Institutet

    collaborator OTHER

  • Evira AB

    collaborator INDUSTRY

  • Sheikh Shakhbout Medical City

    lead OTHER

Principal Investigators

  • Asma Deeb, Dr. · Sheikh Shakhbout Medical City Abu Dhabi

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
6 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-01
Primary Completion
2024-06-30
Completion
2024-06-30

Countries

  • United Arab Emirates

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06665893 on ClinicalTrials.gov